CardioVascular BioTherapeutics (fka CVBT)

[walhall]

It's telling that all Venturis Therapeutics's "supporters" (also known as its leadership) seem to only want to discuss are three things:

1) Dan Montano and the events of the past (kind of like how Trump seems to only want to discuss Obama and his "failings" rather than Trump's own disastrous response to the pandemic and his complete failure of leadership)
2) Patents, patents, patents
3) "Other people" saying how "valuable" this bankrupt and completely dead company is

What Venturis Therapeutics DOESN'T talk about are the things that actually matter:

1) Running clinical trials and the strategy here to get the clinical trials back on track after 14 years of none
2) Raising money to pay for and run such clinical trials
3) The business plan going forward.

In all my investment experience, I've never crossed paths with such a pathetic leadership group that seems capable only of excuses and blaming others but never themselves, who never address any real issues, and who 100% lack any sort of accountability. But read the textbooks on the subject--this is entirely consistent with alcoholic co-morbidity.

Speaking of alcoholic....err, accountability, where is the announcement from Venturis Therapeutics about the 2020 shareholders meeting, which was supposed to have happened by now?

(Hint - there will never be another shareholders meeting before the coming bankruptcy and liquidation.)

Here are some answers to these questions:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827